User profiles for JR. Pineda

Jose R. Pineda

Achucarro Basque center for Neuroscience / Euskal Herriko Unibertsitatea (UPV/EHU)
Verified email at achucarro.org
Cited by 2565

[HTML][HTML] Advances and perspectives in dental pulp stem cell based neuroregeneration therapies

…, A Larrañaga, F Unda, JR Sarasua, JR Pineda… - International journal of …, 2021 - mdpi.com
Human dental pulp stem cells (hDPSCs) are some of the most promising stem cell types for
regenerative therapies given their ability to grow in the absence of serum and their realistic …

Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors

…, AR Bryll, NJ Ganem, F Bersani, JR Pineda… - Science, 2015 - science.org
Cancer cells rely on telomerase or the alternative lengthening of telomeres (ALT) pathway
to overcome replicative mortality. ALT is mediated by recombination and is prevalent in a …

Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's …

JM Canals, JR Pineda, JF Torres-Peraza… - Journal of …, 2004 - Soc Neuroscience
The mechanism that controls the selective vulnerability of striatal neurons in Huntington's
disease is unclear. Brain-derived neurotrophic factor (BDNF) protects striatal neurons and is …

[HTML][HTML] Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo …

…, GM Ruiz-Palacios, S Kline, JR Pineda… - The lancet respiratory …, 2021 - thelancet.com
Background Functional impairment of interferon, a natural antiviral component of the
immune system, is associated with the pathogenesis and severity of COVID-19. We aimed to …

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

…, U Sandkovsky, E Almasri, JR Pineda… - The lancet respiratory …, 2022 - thelancet.com
Background Baricitinib and dexamethasone have randomised trials supporting their use for
the treatment of patients with COVID-19. We assessed the combination of baricitinib plus …

[HTML][HTML] Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase

…, FP Cordelières, JA Parker, JR Pineda… - The Journal of …, 2006 - Am Soc Clin Investig
There is no treatment for the neurodegenerative disorder Huntington disease (HD). Cystamine
is a candidate drug; however, the mechanisms by which it operates remain unclear. We …

[HTML][HTML] Notch and Wnt Signaling Modulation to Enhance DPSC Stemness and Therapeutic Potential

V Uribe-Etxebarria, JR Pineda… - International Journal of …, 2023 - mdpi.com
The Dental Pulp of permanent human teeth is home to stem cells with remarkable multilineage
differentiation ability: human Dental Pulp Stem Cells (DPSCs). These cells display a very …

[HTML][HTML] Ciliogenesis is regulated by a huntingtin-HAP1-PCM1 pathway and is altered in Huntington disease

G Keryer, JR Pineda, G Liot, J Kim… - The Journal of …, 2011 - Am Soc Clin Investig
Pineda contributed equally to this work. … Pineda contributed equally to this work. … JR
Pineda was supported by fundación FECYT and Institut Curie. G. Liot was supported by CHDI …

Vascular‐derived TGF‐β increases in the stem cell niche and perturbs neurogenesis during aging and following irradiation in the adult mouse brain

JR Pineda, M Daynac, A Chicheportiche… - EMBO molecular …, 2013 - embopress.org
Neurogenesis decreases during aging and following cranial radiotherapy, causing a
progressive cognitive decline that is currently untreatable. However, functional neural stem cells …

Evolution after anti-TNF discontinuation in patients with inflammatory bowel disease: a multicenter long-term follow-up study

…, L Bujanda, X Cortés, J Tosca, JR Pineda… - Official journal of the …, 2017 - journals.lww.com
OBJECTIVES: The aims of this study were to assess the risk of relapse after discontinuation
of anti-tumor necrosis factor (anti-TNF) drugs in patients with inflammatory bowel disease (…